메뉴 건너뛰기




Volumn 930, Issue , 2013, Pages 104-111

First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma

Author keywords

Bioanalytical method validation; Fluoroquinolone; HPLC; Human plasma; Protein precipitation; Therapeutic drug monitoring

Indexed keywords

BIOANALYTICAL METHODS; FLUOROQUINOLONES; HPLC; HUMAN PLASMAS; PROTEIN PRECIPITATION; THERAPEUTIC DRUG MONITORING;

EID: 84878554595     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.04.036     Document Type: Article
Times cited : (43)

References (33)
  • 28
    • 0003484310 scopus 로고    scopus 로고
    • US Department of Health and Human Services Food and Drug Adm istration, Center for Drug Evaluation and Research (CDER), Rockville, USA, (accessed 21.12.12).
    • Guidance for Industry, Bioanalytical Method Validation 2001, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, USA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatorInformation/Guidances/ucm070107.pdf (accessed 21.12.12).
    • (2001) Guidance for Industry, Bioanalytical Method Validation
  • 29
    • 81055146012 scopus 로고    scopus 로고
    • European Medic es Agency, EMEA/CHMP/EWP/192217/2009, Committee for Medic al Products for Human Use (CHMP), 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom, (accessed 21.12.12).
    • Guideline on Bioanalytical Method Validation 2011, European Medicines Agency, EMEA/CHMP/EWP/192217/2009, Committee for Medicinal Products for Human Use (CHMP), 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf (accessed 21.12.12).
    • (2011) Guideline on Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.